HELIXMITH

Live / Registered — Registered — partial Sections 8 & 15 accepted and acknowledged (as of 28 Jul 2026)

What this means for you

Registered since 12 Nov 2019. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 12 Nov 2029: the §8 & §9 renewal).

Record

Serial number
88166343
Registration number
5906698
Mark type
Word mark
Filed
23 Oct 2018
Published for opposition
28 May 2019
Registered
12 Nov 2019
Next maintenance filing
§8 & §9 renewal, due by 12 Nov 2029 (grace period to 12 May 2030)
Attorney of record
Connie L. Ellerbach

Goods and services

  • Class 005 — Pharmaceuticals: [ reagents for use in veterinary genetic testing for medical use; chemical preparations for pharmaceutical purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; chemical preparations for use in DNA analysis for medical use; drugs for medical purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; reagents for use in medical genetic testing for medical use; pharmaceutical drugs, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; medicines for human purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; pharmaceutical preparations for diagnosis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; ethical medicinal preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; therapeutic drugs and agents, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; biological preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; crude medicines, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; biological preparations for medical use in medical and clinical gene therapy and cell therapy; pharmaceutical preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; biological preparations for medical use, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer ]
  • Class 035 — Advertising and business services: [ Retail store services featuring reagents for use in veterinary genetic testing; retail store services featuring chemical preparations for pharmaceutical purposes; retail store services featuring chemical preparations for use in DNA analysis for medical use; retail store services featuring drugs for medical purposes; retail store services featuring reagents for use in medical genetic testing; retail store services featuring pharmaceutical preparations for diagnosis; retail store services featuring pharmaceutical preparations for the treatment of immune system related diseases and disorders; retail store services featuring ethical medicinal preparations; retail store services featuring therapeutic drugs and agents, retail store services featuring biological preparations for medical use ]
  • Class 042 — Scientific and technological services: Research and development of vaccines and medicines; [ providing information relating to scientific analysis of the genetic information via online networks; ] scientific research in the fields of biomedicine; [ biological information analysis, namely, genetic testing for medical research purposes; biological information analysis, namely, genetic testing for scientific research purposes; research and testing services in the fields of bacteriology and virology; ] drug discovery services; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy relating to the pharmaceutical research and development; pharmaceutical research and development; [ pharmaceutical research services; laboratory research in the field of gene expression; gene analysis for research; ] consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; scientific research in the fields of medicine/health and pharmacology; analysis of human serum for medical research [ ; analysis of human tissues for medical research; blood analysis services ]

Owner

Board proceedings on this mark

Prosecution history

  • 28 Jul 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
  • 28 Jul 2026 — REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
  • 27 Jul 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 24 Apr 2026 — TEAS SECTION 8 & 15 RECEIVED
  • 12 Nov 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 25 Aug 2020 — CORRECTION UNDER SECTION 7 - PROCESSED
  • 10 Aug 2020 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
  • 19 Feb 2020 — POST REGISTRATION ACTION MAILED - SEC. 7
  • 18 Feb 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 18 Feb 2020 — POST REGISTRATION ACTION CORRECTION
  • 18 Feb 2020 — OTQR WITHDRAWAL FROM PUBLICATION
  • 21 Jan 2020 — CORRECTION UNDER SECTION 7 - PROCESSED
  • 21 Jan 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 03 Dec 2019 — TEAS SECTION 7 REQUEST RECEIVED
  • 12 Nov 2019 — REGISTERED-PRINCIPAL REGISTER

View this trademark record on Rightsy